The Loading of Dipyridamole and Calcium Sulfate into the Gelatin-Coated Porous Bioceramics to Synergistically Regulate Segmental Bone Regeneration
Source abstract
Abstract
The treatment of large segmental bone defects has always been a medical challenge. Although various methods have been developed, each of them has its own drawbacks. To overcome the drawbacks, in situ tissue regeneration has bright prospects. Herein, we developed dipyridamole (D)/calcium sulfate (CS)-loaded, gelatin (G)-coated porous β-tricalcium phosphate (TCP) scaffolds using an indirect 3D printing and surface coating method to treat the 15 mm ulnar bone defects of rabbits. In vitro simulation experiments demonstrated that the as-prepared scaffolds could establish a dynamic acidic microenvironment with relative and variable concentrations of D, calcium ion, and phosphate anion. In vitro mesenchymal stem cell (MSC) coculture experiments displayed that four components, G, D, CS and TCP, could synergistically regulate the adhesion, proliferation, recruitment, migration, and osteogenic differentiation of MSCs. In vivo experiments displayed that the as-prepared scaffolds could recruit and capture endogenous MSCs, mediate the ulnar bone defects to bridge within 12 weeks, and match a desirable degradation rate. The as-prepared scaffolds with high in situ osteogenic activity are attributable to the synergistic effect of four components, which regulated the osteoblastic-osteoclastic imbalance of the bone remodeling cycle.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
National Engineering Research Center for Biomaterials, College of Biomedical Engineering
Sichuan University
School of Medicine and Health, Zhengzhou Research Institute
Harbin Institute of Technology
Funding
Jiangsu Provincial Key Research and Development Program · Sichuan University · China Postdoctoral Science Foundation · National Natural Science Foundation of China
References (64)
Show source-provided references
1. 10.1016/j.jot.2019.09.00510.1016/j.jot.2019.09.005 ↗
2. 10.1016/j.biomaterials.2008.12.05010.1016/j.biomaterials.2008.12.050 ↗
3. 10.1097/00005373-199711000-0000910.1097/00005373-199711000-00009 ↗
4. 10.1097/00003086-198906000-0001110.1097/00003086-198906000-00011 ↗
5. 10.1007/s00423-003-0379-110.1007/s00423-003-0379-1 ↗
6. 10.1016/S0736-0266(03)00165-710.1016/S0736-0266(03)00165-7 ↗
7. 10.1097/00005131-200001000-0001110.1097/00005131-200001000-00011 ↗
8. 10.2106/00004623-200305000-0001110.2106/00004623-200305000-00011 ↗
9. 10.1021/acsami.5c0570710.1021/acsami.5c05707 ↗
10. 10.1073/pnas.090544410710.1073/pnas.0905444107 ↗
11. 10.1021/acsami.4c1571910.1021/acsami.4c15719 ↗
12. 10.1038/s41587-023-02090-210.1038/s41587-023-02090-2 ↗
13. 10.1038/s41578-020-0209-x10.1038/s41578-020-0209-x ↗
14. 10.1021/acsami.5c0261810.1021/acsami.5c02618 ↗
15. 10.1038/nrm325410.1038/nrm3254 ↗
16. 10.1016/j.semcdb.2008.07.00410.1016/j.semcdb.2008.07.004 ↗
17. 10.1039/D4TB01088D10.1039/D4TB01088D ↗
18. 10.1016/j.mser.2010.06.01010.1016/j.mser.2010.06.010 ↗
19. 10.1021/acsami.1c0837210.1021/acsami.1c08372 ↗
20. 10.1021/acsami.5c0127110.1021/acsami.5c01271 ↗
21. 10.1021/acsami.4c1521210.1021/acsami.4c15212 ↗
22. 10.1021/acsami.4c1571910.1021/acsami.4c15719 ↗
23. 10.1039/C8TB01638K10.1039/C8TB01638K ↗
24. 10.1021/am506466210.1021/am5064662 ↗
25. 10.1021/acsami.5b0496210.1021/acsami.5b04962 ↗
26. 10.1021/acsami.8b0214110.1021/acsami.8b02141 ↗
27. 10.1016/j.reth.2024.03.01810.1016/j.reth.2024.03.018 ↗
28. 10.1097/BSD.000000000000130110.1097/BSD.0000000000001301 ↗
29. 10.1089/ten.teb.2015.035710.1089/ten.teb.2015.0357 ↗
30. 10.1152/ajpcell.00413.202110.1152/ajpcell.00413.2021 ↗
31. 10.1002/jbm.b.3356110.1002/jbm.b.33561 ↗
32. 10.1002/art.3897110.1002/art.38971 ↗
33. 10.1126/scitranslmed.300339310.1126/scitranslmed.3003393 ↗
34. 10.1016/S0002-9440(10)63749-210.1016/S0002-9440(10)63749-2 ↗
35. 10.1111/bph.1222710.1111/bph.12227 ↗
36. 10.1016/j.ajpath.2011.10.01710.1016/j.ajpath.2011.10.017 ↗
37. 10.15226/jdodt.2021.00112410.15226/jdodt.2021.001124 ↗
38. 10.1039/D5TB01050K10.1039/D5TB01050K ↗
39. 10.3389/fbioe.2014.0008010.3389/fbioe.2014.00080 ↗
40. 10.1039/D3SM01462B10.1039/D3SM01462B ↗
41. 10.1016/j.jddst.2019.10146710.1016/j.jddst.2019.101467 ↗
42. 10.1080/0363904070119920910.1080/03639040701199209 ↗
43. Islam A. · 2025 · 410.1007/978-3-031-91790-5_9 ↗
44. 10.1016/j.biomaterials.2005.01.00610.1016/j.biomaterials.2005.01.006 ↗
45. 10.1016/j.reth.2025.01.02010.1016/j.reth.2025.01.020 ↗
46. 10.1016/j.cell.2006.06.04410.1016/j.cell.2006.06.044 ↗
47. 10.4161/cam.1870210.4161/cam.18702 ↗
48. 10.1074/jbc.270.17.991710.1074/jbc.270.17.9917 ↗
49. 10.1016/j.actbio.2014.02.00410.1016/j.actbio.2014.02.004 ↗
50. 10.1016/S0167-4889(00)00086-010.1016/S0167-4889(00)00086-0 ↗
51. 10.1016/j.canlet.2019.01.00410.1016/j.canlet.2019.01.004 ↗
52. 10.1016/S0031-6997(24)01511-410.1016/S0031-6997(24)01511-4 ↗
53. 10.1146/annurev.pharmtox.41.1.14510.1146/annurev.pharmtox.41.1.145 ↗
54. 10.1152/ajprenal.2001.280.2.F29110.1152/ajprenal.2001.280.2.F291 ↗
55. 10.1254/jjp.87.18110.1254/jjp.87.181 ↗
56. 10.1016/j.cellsig.2009.01.03810.1016/j.cellsig.2009.01.038 ↗
57. 10.1038/nature1158810.1038/nature11588 ↗
58. 10.1210/endo.140.12.719010.1210/endo.140.12.7190 ↗
59. 10.1016/j.biomaterials.2013.03.04010.1016/j.biomaterials.2013.03.040 ↗
60. 10.12182/2024036030110.12182/20240360301 ↗
61. 10.1016/S0002-9440(10)63749-210.1016/S0002-9440(10)63749-2 ↗
62. 10.1016/S0002-9440(10)61170-410.1016/S0002-9440(10)61170-4 ↗
63. 10.1016/0169-328X(94)00193-I10.1016/0169-328X(94)00193-I ↗
64. 10.1152/ajpheart.1999.277.2.H59510.1152/ajpheart.1999.277.2.H595 ↗